
Mylpero 75mg Tablet
Marketer
Viatris
Salt Composition
Clopidogrel (75mg)
Overview Mylpero 75mg Tablet
CardioGuard 75mg tablets are antithrombotic agents, preventing harmful blood clot formation within blood vessels. This reduces the risk of heart attack and stroke, making it a common cardiovascular preventative medication. CardioGuard 75mg is prescribed for individuals at elevated cardiac risk, including those with peripheral artery disease (circulatory issues from narrowed vessels), recent myocardial infarction or cerebrovascular accident, arrhythmias, and post-stent placement. It's also used adjunctively with other medications to treat heart attacks and unstable angina. This medication can be taken with or without food, consistently at the same time daily. Continued use is crucial; discontinuation increases heart attack and stroke risk. The most frequent adverse effect is bleeding, manifesting as bruising, epistaxis, hematuria, melena (dark stools), or heavier menstrual bleeding. Wound healing may be prolonged. While usually mild and self-limiting, persistent or concerning bleeding necessitates immediate medical attention. This medication is contraindicated in individuals with active internal bleeding, such as a peptic ulcer or intracranial hemorrhage. Prior to initiating therapy, inform your physician of any history of bleeding disorders or recent significant injury or surgery. Temporary cessation may be necessary before elective surgery or dental procedures.
Primary Ingredients of Mylpero 75mg Tablet
No information provided. Please provide the text you wish to be rephrased.
Uses of Mylpero 75mg Tablet
Avert cardiac arrest and cerebrovascular accident.
Major Benefits of Mylpero 75mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Mylpero 75mg Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Mylpero 75mg Tablet:
- Abdominal pain
- Bruise
- Diarrhea
- Hematoma
- Nosebleeds
- Gastrointestinal bleeding
- Dyspepsia
How to use Mylpero 75mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Mylpero 75mg Tablets can be consumed with or without food, although consistent timing is recommended.
How Mylpero 75mg Tablet works:
Aggrenox 75mg tablets inhibit platelet aggregation, thus reducing the risk of dangerous blood clots and consequently lowering the likelihood of a heart attack or stroke.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol with Mylpero 75mg tablets requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Mylpero 75mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Consult your physician for advice.
Breast feedingSAFE IF PRESCRIBED
The use of Mylpero 75mg tablets while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Mylpero 75mg tablets.
KidneySAFE IF PRESCRIBED
In patients with kidney impairment, Mylpero 75mg tablets are considered safe for administration. No alteration of the Mylpero 75mg tablet dosage is necessary.
LiverSAFE IF PRESCRIBED
Mylpero 75mg tablets can be used safely by individuals with hepatic impairment. No alteration to the Mylpero 75mg tablet dosage is necessary.
What if you forget to take Mylpero 75mg Tablet :
Should you forget to take a Mylpero 75mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Mylpero 75mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Amino acid α-esters |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Action Category | ADP receptor antagonists (P2Y12 inhibitors) |
